Recent advances in the study of cuproptosis in gliomas

Gliomas, characterized as highly invasive brain tumors, often render traditional therapies ineffective. Cuproptosis, a recently identified mode of cell death, exhibits mechanisms distinctly different from traditional apoptotic pathways. This process involves the disruption of the mitochondrial tricarboxylic acid cycle by excessive copper ions, leading to cell death. This unique cell death pathway has demonstrated significant potential in the treatment of gliomas. Research has shown that genes associated with cuproptosis, such as FDX1 and LIAS, are aberrantly expressed in gliomas, affecting tumor metabolism and closely correlating with prognosis. Copper chelators, such as trientine and disulfiram, can regulate intracellular copper levels and induce glioma cell death, thereby enhancing the efficacy of chemotherapy. However, the specific mechanisms of cuproptosis and its clinical application in glioma treatment require further exploration. This field of study promises to offer novel insights and directions for developing more effective glioma therapies.